FOR IMMEDIATE RELEASE
Monday, Sept. 28, 2020
KINGSTON, Ont. – Queen’s University announced that it has entered into a research collaboration and licensing agreement with Taysha Gene Therapies, Inc., for the development and commercialization of gene therapy for GM2 gangliosidoses.
The GM2 gangliosidoses are a group of degenerative/inflammatory diseases...Read more
In a Canadian first, a hybrid cardiac ablation procedure has been successfully completed at Kingston Health Sciences Centre (KHSC). The procedure is a revolutionary treatment for patients who suffer from atrial fibrillation - the most common type of irregular heart rhythm.
The new procedure will help patients heal faster, stop...Read more
Kingston General Hospital, (KGH) the first hospital in Canada to complete a blue light cystoscopy outside of a clinical trial, will soon begin offering the procedure on regular basis to improve the quality of life for patients living with bladder cancer in Southeastern Ontario.
The procedure combines a...Read more
A synthetic stool treatment tested at Kingston General Hospital has been getting quite a bit of national and international attention, and with good reason. The proof-of-concept trial has been shown to cure those experiencing chronic C. difficile infections.
The results of the trial were just published...Read more
A synthetic stool treatment transplanted during a proof-of-concept trial at Kingston General Hospital has been shown to cure those who experience chronic C. difficile infections.
The results of the trial were published in Microbiome, a peer-reviewed scientific journal and were part of a co-authored study written by...Read more